article thumbnail

The Role of ERP in the Pharmaceutical Industry

Navigator SAP

The pharmaceutical industry has been transformed in recent years by pressure from intensely competitive markets and the need to comply with new regulations that mandate the highest quality standards across all processes. Life Sciences ERP Software Pharmaceutical

article thumbnail

Why SAP ERP Makes Sense for Pharmaceutical Manufacturing

Navigator SAP

Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Operational Challenges In The Pharmaceutical Industry

Navigator SAP

Without the robust pharmaceutical sector, many people throughout the world would have been wiped out long ago by even mild illnesses. PharmaceuticalUnfortunately, this industry is constantly facing many challenges, most of which are operational.

article thumbnail

How to Compare ERP Systems for Pharmaceuticals

Navigator SAP

As a pharmaceutical company, you’ll face numerous business challenges, most of which require specialized attention and full integration of critical systems and operations.

article thumbnail

Why Is Traceability Important In The Pharmaceutical Industry?

Navigator SAP

Consumer health and safety is the fundamental responsibility of a pharmaceutical company. To avoid this, the pharmaceutical supply chain is one of the most heavily regulated supply chains in the world. Life Sciences Traceability Pharmaceutical

article thumbnail

What is an ERP System in the Pharmaceutical industry?

Navigator SAP

The flow of processes and operations in a pharmaceutical company is extremely complex and labor-intensive, owing to stringent production regulations and competitive market demands. Life Sciences ERP Software Pharmaceutical

article thumbnail

Steps of Quality Control in the Pharmaceutical Industry

Navigator SAP

But what exactly are the steps of quality control in the pharmaceutical industry If you've been reading about ERP systems for medical devices or ERP systems in the pharma industry , you know that quality control regulations have grown more stringent over the last few years.

article thumbnail

FCF Pharmaceutical Market Study – 2022

Fox Corporate Finance

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2022”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.

article thumbnail

Advancing real-world evidence for pharmaceutical companies in Japan

McKinsey

Insights on Life Sciences Pharmaceuticals JapanPharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.

article thumbnail

Developing pharmaceutical launch leaders and company-wide capabilities at scale

McKinsey Public & Social Sector Insights

Insights on Life Sciences PharmaceuticalsBy building certain functional and leadership skills, pharma companies can not only improve the odds of a successful launch but also strengthen their organizations for the future.

article thumbnail

FCF Pharmaceutical Market Study – 2021 published

Fox Corporate Finance

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2021”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.

article thumbnail

Alibaba Raises $1.3B For Push Into eCommerce Pharmaceutical Business

PYMNTS

billion it raised in a secondary offering on the Hong Kong stock exchange to expand its eCommerce pharmaceutical business as it rides a wave of growth amid the coronavirus. Alibaba Health Information Technology plans to pump the $1.3

article thumbnail

Supplylogix Secures Pharmaceutical Inventory Management Patent

PYMNTS

The company targets the pharmaceutical industry, and its patent will enable industry players to transfer inventory of medications based on demand, the firm said. “We The pharmaceutical industry is active in the exploration of tech and FinTech to enhance supply chain and other business management processes. B2B Payments B2B inventory management logistics News patent pharmaceuticals Supplylogix What's Hot In B2B

article thumbnail

Pharmaceutical companies step up hiring of sales representatives to expand market share

CFO News

Industry executives and headhunters told ET that salesforce is needed as they launch more products targeting chronic therapeutic segments such as diabetes, heart failure, central nervous system and respiratory.

article thumbnail

Johnson & Johnson Sales Rise 8.3 Pct Amid Consumer Health, Pharmaceutical Growth

PYMNTS

percent from Q4 2019 to Q4 2020, as consumer health and pharmaceutical sales rose while medical devices worldwide operational sales fell amid the pandemic. It reported that pharmaceutical worldwide operational sales grew by 8.4 Johnson & Johnson reported on Tuesday (Jan.

article thumbnail

Snap Seeks Ads From Pharmaceutical Companies

PYMNTS

In an effort to have big pharma companies advertise on Snapchat , the social media platform is reportedly pitching itself as a friendlier alternative to Twitter and Facebook. The idea is that younger people might be more open to ads focusing on health matters — and may be more comfortable talking about private matters on the platform, CNBC reported. The social media company had a team speak at the DigiPharma Connect conference in February.

article thumbnail

CDMOs, CMOs and CROs: What's the Difference?

Navigator SAP

The pharmaceutical industry has undergone significant evolution within the past 15 years. Pharmaceutical CDMOsRecently, biopharmaceutical companies have become increasingly reliant on outsourced contract services for various elements of their value chain.

SAP 207
article thumbnail

IBM Targets Pharmaceuticals With Blockchain Supply Chain Tech

PYMNTS

As IBM continues its exploration of how blockchain could disrupt supply chain management, the technology firm has partnered with Hejia to introduce a solution targeting the pharmaceutical space. Reports this week said the companies have together launched a blockchain-based supply chain finance solution targeting procurement processes in pharmaceuticals.

article thumbnail

Cloud Computing in Pharma

Navigator SAP

One industry that is slowly adopting cloud computing technology is the pharmaceutical sector. The uptake of this technology in the pharmaceutical industry remains somewhat measured due to strict protocols and compliance regulations. cloud computing Pharmaceutical

SAP 130
article thumbnail

The health benefits and business potential of digital therapeutics

McKinsey Public & Social Sector Insights

Insights on Life Sciences PharmaceuticalsDigital-native start-ups and healthcare incumbents can both play important roles in building and scaling digital therapeutics to improve the management of chronic health conditions.

article thumbnail

What is SOX Compliance in Pharma?

Navigator SAP

Life Sciences PharmaceuticalAutomation of key business processes in the life science industry has profound benefits. SAP ERP is one such tool that allows companies in the life science industry to do just that.

article thumbnail

GMP Guidelines in Pharma Industry

Navigator SAP

The pharmaceutical industry is one of the most heavily regulated industries due to the implications product quality has on public health. Life Sciences Bio Pharma Pharmaceutical

SAP 130
article thumbnail

A Chronic Disease Still Waiting for a Drug

CFO News Room

Take Intercept Pharmaceuticals which at the height of the Wall Street excitement over NASH treatments fetched as much as $462 a share. Drug companies have developed treatments for some of the rarest diseases afflicting a tiny percentage of the population, yet they have failed repeatedly to get a drug on the market for a chronic and increasingly common one.

article thumbnail

Top ten observations from 2022 in life sciences digital and analytics

McKinsey Public & Social Sector Insights

Insights on Life Sciences Pharmaceuticals DigitalLife sciences companies are making progress in adopting and deploying digital and analytics. But they can go further and faster by heeding some lessons from the past few years.

article thumbnail

Developing a customer-centric approach to rare conditions

McKinsey Public & Social Sector Insights

Roche Pharmaceuticals’ approach to rare conditions highlights industry efforts to make a difference for patients, their caregivers, and healthcare professionals. Insights on Life Sciences Pharmaceuticals Medical products

article thumbnail

Pfizer to Buy Rest of Biohaven for $11.6 Billion

CFO News Room

Pfizer on Tuesday said it agreed to buy the rest of Biohaven Pharmaceutical Holding for about $11.6 billion, giving the New York drugmaker full ownership of the Nurtec ODT migraine franchise. Pfizer said it would pay $148.50

article thumbnail

Health equity: A framework for the epidemiology of care

McKinsey

Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust. Insights on Life Sciences Health care reform Pharmaceuticals

article thumbnail

How Daiichi Sankyo Europe drives growth with digital and analytics

McKinsey Public & Social Sector Insights

Insights on Life Sciences Pharmaceuticals Digital strategy and organizationDigital and analytics can markedly improve life sciences companies’ engagement with customers.

article thumbnail

Real-world data quality: What are the opportunities and challenges?

McKinsey Public & Social Sector Insights

Insights on Life Sciences PharmaceuticalsGrowth in the availability and variety of real-world data, including nonhealth sources of data, opens up new opportunities, as well as challenges, in their application to real-world evidence and improving health outcomes.

article thumbnail

How sterile pharma manufacturers can grow capacity without capital investment

McKinsey Public & Social Sector Insights

Insights on Life Sciences PharmaceuticalsThe world will need more sterile products than manufacturers have or can build capacity for. But they can create capacity and take market share by running higher volumes through their existing lines.

article thumbnail

Fewer Cures, Costlier Energy – WSJ

CFO News Room

The bill has many moving parts, but here’s a simple way to sum up its macroeconomic impact: It would transfer about a quarter of a trillion dollars from America’s pharmaceutical industry, which saves and extends lives, to the climate-change industrial complex, which makes energy more expensive. By Stephen Moore and Tomas J. Philipson. 7, 2022 12:52 pm ET. The so-called Inflation Reduction Act will be one of the greatest misallocations of federal resources in American history.

article thumbnail

Building greater resilience in vaccine manufacturing

McKinsey Public & Social Sector Insights

Public & Social Sector Insights Public health Public & Social Sector Pharmaceuticals Europe North and Central AmericaThe COVID-19 pandemic has highlighted the need for resilience in vaccine manufacturing. Five considerations can help national public-health leaders plan.

article thumbnail

Netflix, Alphabet, Nordstrom, PagerDuty, more

CFO News Room

” Eli Lilly — Shares of the pharmaceutical company slumped more than 1% in premarket after the U.S. Regeneron Pharmaceuticals — The pharmaceutical giant gained 1% in the premarket after being upgraded to overweight from neutral by JPMorgan.

CFO 130
article thumbnail

Women in healthcare and life sciences: The ongoing stress of COVID-19

McKinsey

Insights on Healthcare Systems & Services Health care providers PharmaceuticalsThe healthcare sector is examining how to better hire and promote women to the highest levels.

article thumbnail

Pharma CFO Anthony Doyle Plans for Uncertainty

CFO

In the pharmaceutical industry, The post Pharma CFO Anthony Doyle Plans for Uncertainty appeared first on CFO. Q&A capital raising Clinical Trial dilution pharmaceuticals Planning